Related references
Note: Only part of the references are listed.Five-Year Risk of Recurrence After Treatment of CIN 2, CIN 3, or AIS: Performance of HPV and Pap Cotesting in Posttreatment Management
Hormuzd A. Katki et al.
JOURNAL OF LOWER GENITAL TRACT DISEASE (2013)
High-risk human papillomavirus testing versus cytology in predicting post-treatment disease in women treated for high-grade cervical disease: A systematic review and meta-analysis
Marielle Kocken et al.
GYNECOLOGIC ONCOLOGY (2012)
Long-term risk of recurrent cervical human papillomavirus infection and precancer and cancer following excisional treatment
Aimee R. Kreimer et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Evidence Regarding Human Papillomavirus Testing in Secondary Prevention of Cervical Cancer
Marc Arbyn et al.
VACCINE (2012)
Type-specific HPV geno-typing improves detection of recurrent high-grade cervical neoplasia after conisation
Julie Heymans et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Risk of recurrent high-grade cervical intraepithelial neoplasia after successful treatment: a long-term multi-cohort study
Marielle Kocken et al.
LANCET ONCOLOGY (2011)
High-risk human papillomavirus testing for monitoring patients treated for high-grade cervical intraepithelial neoplasia
Nan Hee Jeong et al.
JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH (2009)
A review of human carcinogens-Part B: biological agents
Veronique Bouvard et al.
LANCET ONCOLOGY (2009)
Persistence of human papillomavirus as a predictor for treatment failure after loop electrosurgical excision procedure
J. H. Bae et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2007)
HPV type-specific risks of high-grade CIN during 4 years of follow-up:: A population-based prospective study
P. Naucler et al.
BRITISH JOURNAL OF CANCER (2007)
Cost-effectiveness of human papillomavirus testing after treatment for cervical intraepithelial neoplasia
V. M. H. Coupe et al.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2007)
Viral determinants of human papillomavirus persistence following loop electrical excision procedure treatment for cervical Intraepithelial neoplasia grade 2 or 3
Aimee R. Kreimer et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2007)
Prediction of recurrence after treatment for high-grade cervical intraepithelial neoplasia: the role of human papillomavirus testing and age at conisation
J. Verguts et al.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2006)
Comparison between the hybrid capture II test and a PCR-based human papillomavirus detection method for diagnosis and posttreatment follow-up of cervical intraepithelial neoplasia
A Söderlund-Strand et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2005)
Human papillomavirus genotype distribution in low-grade cervical lesions: Comparison by geographic region and with cervical cancer.
GM Clifford et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2005)
The role of HPV DNA testing in the follow-up period after treatment for CIN: a systematic review of the literature
E Paraskevaidis et al.
CANCER TREATMENT REVIEWS (2004)
HPV testing can reduce the number of follow-up visits in women treated for cervical intraepithelial neoplasia grade 3
GD Zielinski et al.
GYNECOLOGIC ONCOLOGY (2003)
Factors predicting human papillomavirus clearance in cervical intraepithelial neoplasia lesions treated by conization
S Costa et al.
GYNECOLOGIC ONCOLOGY (2003)
Rate of human papillomavirus clearance after treatment of cervical intraepithelial neoplasia
K Elfgren et al.
OBSTETRICS AND GYNECOLOGY (2002)
Type specific persistence of high risk human papillomavirus (HPV) as indicator of high grade cervical squamous intraepithelial lesions in young women: population based prospective follow up study
SK Kjaer et al.
BRITISH MEDICAL JOURNAL (2002)
Detection of residual disease by cytology in patients with cervical intraepithelial neoplasia III post-large loop excision of the transformation zone
S Tangtrakul et al.
JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH (2002)
Is high-risk human papillomavirus infection associated with cervical intraepithelial neoplasia eliminated after conization by large-loop excision of the transformation zone?
E Kucera et al.
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2001)
Persistence of human papillomavirus infection after therapeutic conization for CIN 3: Is it an alarm for disease recurrence?
Y Nagai et al.
GYNECOLOGIC ONCOLOGY (2000)
Regular disappearance of the human papillomavirus genome after conization of cervical dysplasia by carbon dioxide laser
L Kjellberg et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2000)
Share Paper
